| - GRCh38:
- Chr16:3818098-3858843
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Aug 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3789651
- GRCh38:
- Chr16:3739650
| CREBBP | D1365G, D1403G | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely benign (Jan 19, 2023) | criteria provided, single submitter |
| | CREBBP | L2159fs, L2197fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr16:3843509
- GRCh38:
- Chr16:3793508
| CREBBP | H365P | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Jun 26, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3828011
- GRCh38:
- Chr16:3778010
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:3786194
- GRCh38:
- Chr16:3736193
| CREBBP | K1486R, K1524R | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Oct 19, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr16:3807328
- GRCh38:
- Chr16:3757327
| CREBBP | T1182I, T1220I | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 | Likely benign (Jun 21, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3843535
- GRCh38:
- Chr16:3793534
| CREBBP | Q356fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Apr 1, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3767420-3860782
| CREBBP, TRAP1 | | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Mar 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3778879
- GRCh38:
- Chr16:3728878
| CREBBP | Q2019*, Q2057* | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3820750
- GRCh38:
- Chr16:3770749
| CREBBP | P863S, P901S | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Feb 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3801818
- GRCh38:
- Chr16:3751817
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3828768-3828775
- GRCh38:
- Chr16:3778767-3778774
| CREBBP | D585fs, D623fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Jan 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr22:41547912
- GRCh38:
- Chr22:41151908
| EP300, LOC126863158 | Q939*, Q965* | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3786197-3786198
- GRCh38:
- Chr16:3736196-3736197
| CREBBP | F1485fs, F1523fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Jan 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3786099
- GRCh38:
- Chr16:3736098
| CREBBP | L1556V, L1518V | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3900907
- GRCh38:
- Chr16:3850906
| CREBBP | A64fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:3807892-3807915
- GRCh38:
- Chr16:3757891-3757914
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:3860704
- GRCh38:
- Chr16:3810703
| CREBBP | G292E | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779365
- GRCh38:
- Chr16:3729364
| CREBBP | Q1857*, Q1895* | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3817808
- GRCh38:
- Chr16:3767807
| CREBBP | V1017L, V1055L | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3843513
- GRCh38:
- Chr16:3793512
| CREBBP | A364P | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely benign (Jun 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779042-3779043
- GRCh38:
- Chr16:3729041-3729042
| CREBBP | V1964fs, V2002fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Mar 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3789608
- GRCh38:
- Chr16:3739607
| CREBBP | Y1379*, Y1417* | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3801757
- GRCh38:
- Chr16:3751756
| CREBBP | T1212N, T1250N | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3830780
- GRCh38:
- Chr16:3780779
| CREBBP | W554C, W592C | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Oct 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779806
- GRCh38:
- Chr16:3729805
| CREBBP | G1710C, G1748C | Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Oct 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3790462-3790466
- GRCh38:
- Chr16:3740461-3740465
| CREBBP | E1318fs, E1356fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3860728
- GRCh38:
- Chr16:3810727
| CREBBP | G284fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:3786111-3786115
- GRCh38:
- Chr16:3736110-3736114
| CREBBP | E1513fs, E1551fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:3778489
- GRCh38:
- Chr16:3728488
| CREBBP | P2149S, P2187S | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Sep 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3828693
- GRCh38:
- Chr16:3778692
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Sep 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3778491
- GRCh38:
- Chr16:3728490
| CREBBP | N2148I, N2186I | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779244
- GRCh38:
- Chr16:3729243
| CREBBP | T1897I, T1935I | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jun 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3786792
- GRCh38:
- Chr16:3736791
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome | Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:3794903
- GRCh38:
- Chr16:3744902
| CREBBP | S1287I, S1325I | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, See cases
| Uncertain significance (Aug 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3795285
- GRCh38:
- Chr16:3745284
| CREBBP | P1265S, P1303S | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3790551
- GRCh38:
- Chr16:3740550
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3807934
- GRCh38:
- Chr16:3757933
| CREBBP | N1124S, N1162S | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, not specified
| Uncertain significance (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3781196
- GRCh38:
- Chr16:3731195
| CREBBP | C1685W, C1723W | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779473-3779493
- GRCh38:
- Chr16:3729472-3729492
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3823778-3823779
- GRCh38:
- Chr16:3773777-3773778
| CREBBP | P775fs, P813fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3781863
- GRCh38:
- Chr16:3731862
| CREBBP | R1564S, R1602S | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Apr 8, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3788649
- GRCh38:
- Chr16:3738648
| CREBBP | D1397E, D1435E | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779338
- GRCh38:
- Chr16:3729337
| CREBBP | Q1866*, Q1904* | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3799632
- GRCh38:
- Chr16:3749631
| CREBBP | E1240Q, E1278Q | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Aug 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3828731
- GRCh38:
- Chr16:3778730
| CREBBP | D601fs, D639fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Apr 20, 2022) | criteria provided, single submitter |
| | CREBBP | M1950fs, M1988fs | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 | Likely pathogenic (Feb 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3808972
- GRCh38:
- Chr16:3758971
| CREBBP | | Rubinstein-Taybi syndrome, Inborn genetic diseases, Rubinstein-Taybi syndrome due to CREBBP mutations
| Likely benign (Jun 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3777932
- GRCh38:
- Chr16:3727931
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome
| Likely benign (Jun 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3817767
- GRCh38:
- Chr16:3767766
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome
| Likely benign (Mar 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3808066
- GRCh38:
- Chr16:3758065
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome
| Likely benign (Aug 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3828712
- GRCh38:
- Chr16:3778711
| CREBBP | A606P, A644P | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Feb 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr22:41513550
- GRCh38:
- Chr22:41117546
| EP300 | G152S | Inborn genetic diseases, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 2, Colorectal cancer, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
| Conflicting interpretations of pathogenicity (Oct 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:3781374
- GRCh38:
- Chr16:3731373
| CREBBP | R1626L, R1664L | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779254
- GRCh38:
- Chr16:3729253
| CREBBP | T1894A, T1932A | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations | Conflicting interpretations of pathogenicity (Jul 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:3779201-3779202
- GRCh38:
- Chr16:3729200-3729201
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Mar 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3860701
- GRCh38:
- Chr16:3810700
| CREBBP | V293E | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jun 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3807848
- GRCh38:
- Chr16:3757847
| CREBBP | P1153T, P1191T | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr16:3786056
- GRCh38:
- Chr16:3736055
| CREBBP | A1532V, A1570V | not specified, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
| Uncertain significance (Jan 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3794937
- GRCh38:
- Chr16:3744936
| CREBBP | K1276*, K1314* | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3808001
- GRCh38:
- Chr16:3758000
| CREBBP | R1102fs, R1140fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3808051
- GRCh38:
- Chr16:3758050
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3790520
- GRCh38:
- Chr16:3740519
| CREBBP | L1300W, L1338W | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3823912
- GRCh38:
- Chr16:3773911
| CREBBP | R730Q, R768Q | not provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
| Uncertain significance (Apr 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3817722
- GRCh38:
- Chr16:3767721
| CREBBP | K1045N, K1083N | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Aug 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3779586
- GRCh38:
- Chr16:3729585
| CREBBP | Q1783R, Q1821R | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 | Uncertain significance (Nov 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3900384
- GRCh38:
- Chr16:3850383
| CREBBP | V238M | not provided, Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 | Benign/Likely benign (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3778440-3778445
- GRCh38:
- Chr16:3728439-3728444
| CREBBP | | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome, not provided | Uncertain significance (Nov 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3778724
- GRCh38:
- Chr16:3728723
| CREBBP | Y2070*, Y2108* | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Oct 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3820853
- GRCh38:
- Chr16:3770852
| CREBBP | M828I, M866I | Inborn genetic diseases, Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, not provided | Conflicting interpretations of pathogenicity (Jul 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:3831200-3831203
- GRCh38:
- Chr16:3781199-3781202
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Oct 5, 2021) | no assertion criteria provided |
| - GRCh37:
- Chr16:3779041
- GRCh38:
- Chr16:3729040
| CREBBP | P1965S, P2003S | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Aug 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3817738
- GRCh38:
- Chr16:3767737
| CREBBP | S1040L, S1078L | Rubinstein-Taybi syndrome, not provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 | Uncertain significance (Jul 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3807346
- GRCh38:
- Chr16:3757345
| CREBBP | Y1176C, Y1214C | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, not provided
| Uncertain significance (Feb 22, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3831319
- GRCh38:
- Chr16:3781318
| CREBBP | | Rubinstein-Taybi syndrome, not provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1 | Benign (Oct 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3790412
- GRCh38:
- Chr16:3740411
| CREBBP | G1336A, G1374A | not provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
| Uncertain significance (Oct 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:41545747
- GRCh38:
- Chr22:41149743
| EP300 | | not provided, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 2, Colorectal cancer, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency
| Benign/Likely benign (Aug 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3820605
- GRCh38:
- Chr16:3770604
| CREBBP | P911L, P949L | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, not provided, Rubinstein-Taybi syndrome | Benign/Likely benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3779212
- GRCh38:
- Chr16:3729211
| CREBBP | P1908A, P1946A | Rubinstein-Taybi syndrome, not provided, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Aug 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:3823776
- GRCh38:
- Chr16:3773775
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Inborn genetic diseases, Rubinstein-Taybi syndrome, not provided | Likely benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3778660
- GRCh38:
- Chr16:3728659
| CREBBP | Q2092*, Q2130* | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely pathogenic (Feb 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3798049-3803276
- GRCh38:
- Chr16:3748048-3753275
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Mar 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3820994
- GRCh38:
- Chr16:3770993
| CREBBP | | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome
| Likely benign (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3789718
- GRCh38:
- Chr16:3739717
| CREBBP | D1343N, D1381N | Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1
| Uncertain significance (Jul 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3778209
- GRCh38:
- Chr16:3728208
| CREBBP | G2242E, G2280E | Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome | Uncertain significance (Sep 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3795299
- GRCh38:
- Chr16:3745298
| CREBBP | Y1260C, Y1298C | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jun 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3808854
- GRCh38:
- Chr16:3758853
| CREBBP | | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Jan 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3781305
- GRCh38:
- Chr16:3731304
| CREBBP | S1649F, S1687F | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome
| Likely pathogenic (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr22:41513791
- GRCh38:
- Chr22:41117787
| EP300 | G232A | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Menke-Hennekam syndrome 2, Colorectal cancer | Conflicting interpretations of pathogenicity (Aug 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:3831254
- GRCh38:
- Chr16:3781253
| CREBBP | P505A, P543A | Rubinstein-Taybi syndrome due to CREBBP mutations | Likely benign (May 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3929849
- GRCh38:
- Chr16:3879848
| CREBBP | | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Tip-toe gait
| Uncertain significance (Sep 22, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3900857
- GRCh38:
- Chr16:3850856
| CREBBP | S80C | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Feb 21, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3777864
- GRCh38:
- Chr16:3727863
| CREBBP | I2395T, I2357T | Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations
| Uncertain significance (Sep 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:3779206
- GRCh38:
- Chr16:3729205
| CREBBP | P1910T, P1948T | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jun 4, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3929870-3929871
- GRCh38:
- Chr16:3879869-3879870
| CREBBP | K16fs | Rubinstein-Taybi syndrome due to CREBBP mutations | Pathogenic (Jan 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3799628
- GRCh38:
- Chr16:3749627
| CREBBP | P1241R, P1279R | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Mar 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3817744
- GRCh38:
- Chr16:3767743
| CREBBP | S1038F, S1076F | Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jul 10, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3929813-4387545
| TFAP4, CREBBP, GLIS2, ADCY9, SRL | | Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations | Uncertain significance (Jul 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:3820597
- GRCh38:
- Chr16:3770596
| CREBBP | V914M, V952M | Rubinstein-Taybi syndrome due to CREBBP mutations, Menke-Hennekam syndrome 1, Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations | Conflicting interpretations of pathogenicity (Jul 12, 2022) | criteria provided, conflicting interpretations |